bioAffinity Technologies Inc Share Price Today: Live Updates & Key Insights

bioAffinity Technologies Inc share price today is $2.89, up -8.08%. The stock opened at $3.49 against the previous close of $2.97, with an intraday high of $3.58 and low of $2.61.

bioAffinity Technologies Inc Share Price Chart

bioAffinity Technologies Inc

us-stock
To Invest in {{usstockname}}
us-stock

bioAffinity Technologies Inc Share Price Performance

$2.89 -0.0808(-8.08%) BIAF at 23 Mar 2026 12:12 PM Diagnostics & Research
Lowest Today 2.61
Highest Today 3.58
Today’s Open 3.49
Prev. Close 2.97
52 Week High 46.53
52 Week Low 0.69
Day’s Range: Low 2.61 High 3.58
52-Week Range: Low 0.69 High 46.53
1 day return -
1 Week return +43.3
1 month return +196.06
3 month return +111.62
6 month return -48.0
1 year return +892.72
3 year return +51.66
5 year return -
10 year return -

bioAffinity Technologies Inc Institutional Holdings

Abante Quant Value FI 1.25

Geode Capital Management, LLC 0.88

Fidelity Extended Market Index 0.74

Scientech Research LLC 0.48

NT Ext Equity Mkt Idx Fd - L 0.36

Citadel Advisors Llc 0.34

TWO SIGMA SECURITIES, LLC 0.32

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.14

Fidelity Series Total Market Index 0.13

Tower Research Capital LLC 0.11

Spartan Total Market Index Pool G 0.09

Bank of America Corp 0.05

Vanguard Institutional Extnd Mkt Idx Tr 0.03

IFP Advisors, LLC 0.02

Fidelity Nasdaq Composite Index 0.02

Fidelity Total Market Index 0.01

NT Ext Equity Mkt Idx Fd - NL 0.01

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.01

Northern Trust Extended Eq Market Idx 0.00

UBS Group AG 0.00

Spartan Extended Market Index Pool F 0.00

Citigroup Inc 0.00

Morgan Stanley - Brokerage Accounts 0.00

CapTrust Financial Advisors 0.00

Creative Planning Inc 0.00

FMR Inc 0.00

Hanson Mcclain Inc 0.00

Larson Financial Group, LLC 0.00

Northern Trust Corp 0.00

Sabby Management LLC 0.00

State Street Corp 0.00

StoneX Group Inc 0.00

Vanguard Group Inc 0.00

bioAffinity Technologies Inc Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

bioAffinity Technologies Inc Fundamentals

Market Cap 12.28 M

PB Ratio 1.6876

PE Ratio 0.0

Enterprise Value 6.99 M

Total Assets 10.96 M

Volume 14560880

bioAffinity Technologies Inc Company Financials

Annual Revenue FY23:321489 0.3M, FY22:4803 0.0M, FY21:0 0.0M, FY20:0 0.0M

Annual Profit FY23:245289 0.2M, FY22:4336 0.0M, FY21:null 0.0M, FY20:null 0.0M

Annual Net worth FY23:-7238430 -7.2M, FY22:-8154113 -8.2M, FY21:-6326413 -6.3M, FY20:-7268737 -7.3M

Quarterly Revenue Q3/2025:1446066 1.4M, Q2/2025:1269483 1.3M, Q1/2025:1853597 1.9M, Q3/2024:2350386 2.4M, Q2/2024:2397652 2.4M

Quarterly Profit Q3/2025:390495 0.4M, Q2/2025:252881 0.3M, Q1/2025:485737 0.5M, Q3/2024:910228 0.9M, Q2/2024:989942 1.0M

Quarterly Net worth Q3/2025:-5051084 -5.1M, Q2/2025:-4060787 -4.1M, Q1/2025:-2660417 -2.7M, Q3/2024:-2000840 -2.0M, Q2/2024:-2110279 -2.1M

About bioAffinity Technologies Inc & investment objective

Company Information bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

Organisation Diagnostics & Research

Employees 57

Industry Diagnostics & Research

CEO Ms. Maria Zannes J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

bioAffinity Technologies Inc FAQs

What is the share price of bioAffinity Technologies Inc today?

The current share price of bioAffinity Technologies Inc is $2.89.

Can I buy bioAffinity Technologies Inc shares in India?

Yes, Indian investors can buy bioAffinity Technologies Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy bioAffinity Technologies Inc shares in India?

You can easily invest in bioAffinity Technologies Inc shares from India by:

Can I buy fractional shares of bioAffinity Technologies Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of bioAffinity Technologies Inc?

bioAffinity Technologies Inc has a market cap of $12.28 M.

In which sector does bioAffinity Technologies Inc belong?

bioAffinity Technologies Inc operates in the Diagnostics & Research sector.

What documents are required to invest in bioAffinity Technologies Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of bioAffinity Technologies Inc?

The PE ratio of bioAffinity Technologies Inc is N/A and the PB ratio is 1.69.